Unchained Labs develops purpose-built analytical and automation tools for biologics, gene therapy, cell therapy, nanoparticles, exosomes, and genomics research. Its platforms help researchers address key development challenges including protein stability and aggregation, concentration and sizing, viscosity, buffer exchange, viral vector characterization, nanoparticle formulation, and nucleic acid analysis.
The company’s portfolio combines technologies such as dynamic light scattering, differential scanning fluorimetry, UV/Vis spectroscopy, microfluidic mixing, ultrafiltration and diafiltration, and single-particle interferometry with AI-driven laboratory automation. Unchained Labs is increasingly focused on supporting AI-driven labs through integrated workflows that connect experimental planning, automated execution, analytical measurements, and structured data generation.
